Amgen Inc. buy marge
Start price
21.06.15
/
50%
€141.91
Target price
24.05.16
€160.00
Performance (%)
-3.29%
End price
24.05.16
€134.02
Summary
This prediction ended on 24.05.16 with a price of €134.02. With a performance of -3.29%, the BUY prediction for Amgen Inc. by marge closed slightly in the red. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Amgen Inc. | 0.374% | 0.374% | 43.773% | 51.363% |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by marge for this prediction
In the thread Amgen Inc. diskutieren
Amgen
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)